James Shin
Stock Analyst at Deutsche Bank
(1.34)
# 3,333
Out of 4,818 analysts
20
Total ratings
44.44%
Success rate
-2.45%
Average return
Main Sectors:
Top Industries:
Stocks Rated by James Shin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GILD Gilead Sciences | Upgrades: Buy | $80 → $120 | $106.15 | +13.05% | 2 | Feb 18, 2025 | |
| MRK Merck & Co. | Downgrades: Hold | $128 → $105 | $79.84 | +31.51% | 2 | Feb 18, 2025 | |
| LLY Eli Lilly and Company | Maintains: Buy | $1,025 → $1,015 | $859.73 | +18.06% | 4 | Nov 4, 2024 | |
| AMGN Amgen | Reiterates: Hold | $310 → $305 | $279.84 | +8.99% | 2 | Aug 7, 2024 | |
| INCY Incyte | Maintains: Hold | $55 → $60 | $58.97 | +1.75% | 2 | Aug 1, 2024 | |
| BMY Bristol-Myers Squibb Company | Maintains: Hold | $53 → $45 | $48.69 | -7.58% | 2 | Jul 23, 2024 | |
| LEGN Legend Biotech | Initiates: Buy | $60 | $34.24 | +75.23% | 1 | May 23, 2024 | |
| ABBV AbbVie | Initiates: Hold | $150 | $180.37 | -16.84% | 1 | Nov 9, 2023 | |
| REGN Regeneron Pharmaceuticals | Initiates: Hold | $800 | $599.76 | +33.39% | 1 | Nov 9, 2023 | |
| AUTL Autolus Therapeutics | Initiates: Buy | $10 | $1.40 | +614.29% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $1.30 | +823.08% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $80 → $70 | $0.89 | +7,765.17% | 1 | Dec 12, 2022 |
Gilead Sciences
Feb 18, 2025
Upgrades: Buy
Price Target: $80 → $120
Current: $106.15
Upside: +13.05%
Merck & Co.
Feb 18, 2025
Downgrades: Hold
Price Target: $128 → $105
Current: $79.84
Upside: +31.51%
Eli Lilly and Company
Nov 4, 2024
Maintains: Buy
Price Target: $1,025 → $1,015
Current: $859.73
Upside: +18.06%
Amgen
Aug 7, 2024
Reiterates: Hold
Price Target: $310 → $305
Current: $279.84
Upside: +8.99%
Incyte
Aug 1, 2024
Maintains: Hold
Price Target: $55 → $60
Current: $58.97
Upside: +1.75%
Bristol-Myers Squibb Company
Jul 23, 2024
Maintains: Hold
Price Target: $53 → $45
Current: $48.69
Upside: -7.58%
Legend Biotech
May 23, 2024
Initiates: Buy
Price Target: $60
Current: $34.24
Upside: +75.23%
AbbVie
Nov 9, 2023
Initiates: Hold
Price Target: $150
Current: $180.37
Upside: -16.84%
Regeneron Pharmaceuticals
Nov 9, 2023
Initiates: Hold
Price Target: $800
Current: $599.76
Upside: +33.39%
Autolus Therapeutics
Nov 9, 2023
Initiates: Buy
Price Target: $10
Current: $1.40
Upside: +614.29%
Nov 9, 2023
Initiates: Buy
Price Target: $12
Current: $1.30
Upside: +823.08%
Dec 12, 2022
Maintains: Overweight
Price Target: $80 → $70
Current: $0.89
Upside: +7,765.17%